By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Fisher & Paykel Healthcare Corporation Limited

Fisher & Paykel Healthcare Corporation Limited (FSPKF)

OTC Market Data in USD, Fundamentals in NZD
$20.01
$0.00
0.00%
Last Update: 2 Sept 2025, 00:00
$12.80B
Market Cap
30.42
P/E Ratio (TTM)
2.26%
Forward Dividend Yield
$16.35 - $25.91
52 Week Range

FSPKF Stock Price Chart

Explore Fisher & Paykel Healthcare Corporation Limited interactive price chart. Choose custom timeframes to analyze FSPKF price movements and trends.

FSPKF Company Profile

Discover essential business fundamentals and corporate details for Fisher & Paykel Healthcare Corporation Limited (FSPKF) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

IPO Date

11 Jul 2001

Employees

6.98K

CEO

Lewis G. Gradon

Description

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. In addition, it provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

FSPKF Financial Timeline

Browse a chronological timeline of Fisher & Paykel Healthcare Corporation Limited corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 25 May 2026

Upcoming earnings on 25 Nov 2025

Dividend declared on 28 May 2025

A dividend of $0.23 per share was announced, adjusted to $0.22. The dividend was paid on 4 Jul 2025.

Earnings released on 27 May 2025

EPS came in at $0.35 surpassing the estimated $0.20 by +75.12%, while revenue for the quarter reached $709.47M , beating expectations by +17.26%.

Dividend declared on 28 Nov 2024

A dividend of $0.17 per share was announced, adjusted to $0.17. The dividend was paid on 18 Dec 2024.

Earnings released on 27 Nov 2024

EPS came in at $0.16 falling short of the estimated $0.17 by -5.55%, while revenue for the quarter reached $585.97M , missing expectations by -2.30%.

Dividend declared on 29 May 2024

A dividend of $0.22 per share was announced, adjusted to $0.23. The dividend was paid on 10 Jul 2024.

Earnings released on 28 May 2024

EPS came in at $0.03 falling short of the estimated $0.16 by -83.63%, while revenue for the quarter reached $559.06M , beating expectations by +0.40%.

Dividend declared on 29 Nov 2023

A dividend of $0.17 per share was announced, adjusted to $0.17. The dividend was paid on 18 Dec 2023.

Earnings released on 29 Sept 2023

EPS came in at $0.11 surpassing the estimated $0.10 by +4.29%, while revenue for the quarter reached $485.86M , beating expectations by +1.92%.

Dividend declared on 26 May 2023

A dividend of $0.22 per share was announced, adjusted to $0.22. The dividend was paid on 7 Jul 2023.

Earnings released on 31 Mar 2023

EPS came in at $0.17 surpassing the estimated $0.16 by +0.85%, while revenue for the quarter reached $559.66M , beating expectations by +2.03%.

Dividend declared on 29 Nov 2022

A dividend of $0.17 per share was announced, adjusted to $0.17. The dividend was paid on 21 Dec 2022.

Earnings released on 29 Sept 2022

EPS came in at $0.09 surpassing the estimated $0.09 by +5.16%, while revenue for the quarter reached $395.15M , beating expectations by +4.69%.

Dividend declared on 25 May 2022

A dividend of $0.22 per share was announced, adjusted to $0.22. The dividend was paid on 6 Jul 2022.

Earnings released on 31 Mar 2022

EPS came in at $0.19 surpassing the estimated $0.18 by +3.98%, while revenue for the quarter reached $529.11M , missing expectations by -3.27%.

Dividend declared on 25 Nov 2021

A dividend of $0.18 per share was announced, adjusted to $0.18. The dividend was paid on 15 Dec 2021.

Earnings released on 30 Sept 2021

EPS came in at $0.26 surpassing the estimated $0.25 by +7.87%, while revenue for the quarter reached $608.47M , missing expectations by -0.60%.

Dividend declared on 27 May 2021

A dividend of $0.24 per share was announced, adjusted to $0.24. The dividend was paid on 7 Jul 2021.

Earnings released on 31 Mar 2021

EPS came in at $0.36 falling short of the estimated $0.37 by -3.05%, while revenue for the quarter reached $727.79M , missing expectations by -7.86%.

Dividend declared on 25 Nov 2020

A dividend of $0.18 per share was announced, adjusted to $0.18. The dividend was paid on 16 Dec 2020.

Earnings released on 30 Sept 2020

EPS came in at $0.26 surpassing the estimated $0.22 by +15.29%, while revenue for the quarter reached $603.50M , beating expectations by +10.52%.

FSPKF Stock Performance

Access detailed FSPKF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run